Company / Revenue per Share
Idexx Laboratories Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$52.74
FY2025
5-year range
$37.63 / $52.74
FY2021-FY2025
Trend
+12.4%
vs FY2024
Sector context
#39 of 147
Health Care
What the data says
At $52.74, Idexx Laboratories's revenue per share ranks #39 of 147 in the Health Care sector. Revenue per Share has increased for 9 consecutive years, from $17.49 in FY2016 to $52.74 in FY2025.
Based on SEC 10-K filings.
52.74 in FY2025 with a 5-year CAGR of +10.7%.
Improved from $44.16 to $52.74 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +9.8%
- 5-Year CAGR
- +10.7%
- 10-Year CAGR
- -
Sector benchmark
#39 of 147 in Health CareTop 27% of 147This company $52.74 Sector average $127.83
▼
-58.7% below sector average
Key checks
Key Insights
- Idexx Laboratories's revenue per share has grown for 9 consecutive years.
- In FY2025, revenue per share increased 12.4% year-over-year.
- Ranks #39 out of 147 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $52.74 | +12.4% |
| FY2024 | $46.94 | +6.3% |
| FY2023 | $44.16 | +10.9% |
| FY2022 | $39.82 | +5.8% |
| FY2021 | $37.63 | +18.8% |
| FY2020 | $31.67 | +13.3% |
| FY2019 | $27.95 | +10.0% |
| FY2018 | $25.41 | +20.8% |
| FY2017 | $21.03 | +20.2% |
| FY2016 | $17.49 | +17.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026